Stock Ratings / Health Care / TGTX / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

TG Therapeutics Inc. (TGTX) 12-Month Stock Forecast & Price Target Cone

$58.08 +1.19% NASDAQ • Public Delayed / 60s Snapshot

TG Therapeutics Inc. (TGTX) receives a Roarable Rating of D (Sell) and flashes a Red SELL / AVOID warning (60/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+181.1% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.

ROARABLE D • SELL / AVOID Cap $8.89B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE+0.9% Base Target

WHALE OPTIONS TUG-OF-WAR:61% Call Buyers ($2.7M)

39% PutsMax Pain: $57.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your TGTX Position Size: $10,000

Shares at $58.08: 172.2 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $45.71

$7,870

$-2,130 (-21.3%)

12M Consensus BaseTarget $58.60

$10,090

+$90 (+0.9%)

12M Bull Case BreakoutTarget $69.15

$11,906

+$1,906 (+19.1%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$61	74%	A
Goldman SachsSector Coverage Lead	BUY	$65	69%	B
JP MorganUS Large-Cap Research	HOLD	$52	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Forensic Quant Desk

Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring TGTX)

✓Live walkthrough of TGTX's RQD Radar, SEC cash-conversion gap & downside levels
✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
✓Includes instant 24/7 email alert whenever any of your stocks flip to Red

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

TGTX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +81.11%▲ RESISTANCE BREAKOUT

2026-10-30O $58.15H $61.76L $58.00C $61.18VOL 2.85M

RES: $59.92SUP: $52.40SMA50: $55.33SMA200: $43.81

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

TGTX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 TGTX Butterfly Map → + Track TGTX →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

13.4%/yr Implied 5Y Growth

vs. +87.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on TGTX today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for TGTX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for TGTX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

TGTX Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is TGTX's 12-month stock price target?

TG Therapeutics Inc. (TGTX) carries a 12-month consensus base price target of $58.6 (+0.9% from $58.08), with a bull-case target of $69.15 and a bear-case floor of $45.71.